Epidermolysis Bullosa: Pediatric Perspectives

Area of Science:

• Pediatric Dermatology
• Genetics
• Rare Diseases

Background:

• Epidermolysis bullosa (EB) encompasses rare congenital genetic disorders characterized by extreme skin fragility and blistering upon minor trauma.
• Distinguishing between EB types and subtypes is crucial due to significant variations in management and prognosis.

Purpose of the Study:

• To provide an up-to-date literature review on congenital epidermolysis bullosa for pediatric healthcare providers.
• To consolidate information on EB epidemiology, diagnosis, therapy, prognosis, and clinical guidelines.

Main Methods:

• A comprehensive literature review was conducted using PubMed Clinical Queries.
• Search terms included "epidermolysis bullosa", "congenital", and "children" for English-language articles.
• Reviewed literature was categorized by epidemiology, diagnosis, therapy, prognosis, and clinical prediction guidelines.

Main Results:

• EB results from genetic mutations affecting epidermal-dermal adhesion, with four main types: simplex, dystrophic, junctional, and Kindler syndrome.
• Diagnosis relies on clinical presentation, skin biopsy, and genetic testing; severity ranges from mild to fatal.
• Management is multidisciplinary, focusing on wound care, pain control, infection prevention, nutrition, and complication management; no cure exists.

Conclusions:

• Optimal multidisciplinary care is essential for managing epidermolysis bullosa, emphasizing supportive treatments and complication prevention.
• While milder forms have a good prognosis, severe EB significantly impairs quality of life for affected children and families.
• Healthcare providers must recognize the profound suffering associated with EB and offer proactive support to patients and their families.